CHBRF: AI 评分 38/100 — AI 分析 (4月 2026)

Chill Brands Group PLC focuses on the research, development, and sale of cannabidiol (CBD) consumer products and other lifestyle goods across the United States, the United Kingdom, and Europe. The company offers a range of products, including tobacco alternatives and CBD-infused wellness items, marketed under the Chill.com and Zoetic brands.

Key Facts: AI Score: 38/100 Sector: Healthcare

公司概况

概要：

Chill Brands Group PLC is a UK-based company operating in the cannabidiol (CBD) consumer products market, offering tobacco alternatives and wellness products under the Chill.com and Zoetic brands, facing significant competition and financial challenges in the evolving regulatory landscape of the US, UK, and European markets.

CHBRF是做什么的？

Chill Brands Group PLC, formerly known as Zoetic International PLC, was founded in 2014 and rebranded in August 2021 to reflect its strategic focus on the 'Chill' brand. Headquartered in London, the company operates in the cannabidiol (CBD) consumer products and lifestyle goods sector, with a presence in the United States, the United Kingdom, and Europe. Chill Brands develops, produces, and sells a variety of CBD-infused products, including tobacco alternative products such as smokes and chew pouches, catering to consumers seeking alternatives to traditional tobacco products. The company also offers oral tinctures, soft-gel capsules, massage oils, and topical cosmetic products, targeting the broader wellness market. These products are marketed under the Chill.com and Zoetic brands, with the Chill.com brand representing the company's primary focus. Despite its presence in multiple geographic markets, Chill Brands faces challenges related to regulatory uncertainties and intense competition within the rapidly evolving CBD industry. The company's ability to navigate these challenges and establish a sustainable market position will be critical to its long-term success.

CHBRF的投资论点是什么？

Investing in Chill Brands Group PLC (CHBRF) presents significant risks due to its negative profitability, as evidenced by a -547.6% profit margin and a -48.1% gross margin. The company operates in a highly competitive and evolving regulatory environment within the CBD market. While the company has a presence in the US, UK, and Europe, its small market capitalization of $0.02 billion and negative P/E ratio of -1.35 indicate financial instability. Growth catalysts depend heavily on successful product launches and expansion into new markets, which are subject to regulatory approvals and market acceptance. The investment thesis hinges on the company's ability to achieve profitability and navigate the complex regulatory landscape, which is uncertain at this time.

CHBRF在哪个行业运营？

Chill Brands Group PLC operates within the rapidly expanding yet highly fragmented cannabidiol (CBD) market. This market is characterized by evolving regulations, intense competition, and fluctuating consumer demand. The global CBD market is projected to reach billions of dollars in the coming years, driven by increasing consumer awareness of potential health benefits and the legalization of cannabis in various jurisdictions. However, regulatory uncertainties and varying standards across different countries pose significant challenges for companies like Chill Brands. Competitors such as ATHJF (Australis Capital Inc.), BFFTF (BevCanna Enterprises Inc.), EMMLF (Emerald Health Therapeutics Inc.), GENH (General Hemp Corp), and GRAMF (The Gram Co Inc.) are vying for market share, intensifying the competitive landscape.

Drug Manufacturers - Specialty & Generic

Healthcare

CHBRF有哪些增长机遇？

Expansion into new geographic markets represents a significant growth opportunity for Chill Brands. The company currently operates in the US, UK, and Europe, but further expansion into other regions with favorable regulatory environments could drive revenue growth. Successfully entering new markets requires significant investment in marketing, distribution, and regulatory compliance, but the potential rewards could be substantial. The global cannabis market is projected to reach $47 billion by 2027, presenting a large addressable market for Chill Brands.
Development of new CBD-infused products targeting specific health and wellness needs could drive revenue growth and increase market share. Chill Brands currently offers a range of products, including tobacco alternatives, tinctures, and topical creams, but expanding its product portfolio to address specific conditions such as anxiety, sleep disorders, and pain management could attract new customers and increase customer loyalty. This requires investment in research and development, as well as clinical trials to validate the efficacy of new products. The market for CBD-infused health and wellness products is growing rapidly, driven by increasing consumer awareness of potential health benefits.
Strategic partnerships with established retailers and distributors could significantly expand Chill Brands' market reach and increase brand awareness. Collaborating with major retailers in the US, UK, and Europe could provide access to a large customer base and enhance brand visibility. This requires negotiating favorable terms and ensuring consistent product quality and supply. The retail landscape is evolving rapidly, with increasing demand for CBD products in mainstream retail channels.
Focus on building a strong online presence and e-commerce platform could drive direct-to-consumer sales and increase brand loyalty. Investing in search engine optimization (SEO), social media marketing, and targeted advertising could attract new customers and increase online sales. This requires building a user-friendly website, offering competitive pricing, and providing excellent customer service. The e-commerce channel is growing rapidly, driven by increasing consumer preference for online shopping.
Lobbying and advocacy efforts to influence regulatory policies and promote favorable legislation could create a more supportive environment for the CBD industry and benefit Chill Brands. Engaging with policymakers and industry associations to advocate for clear and consistent regulations could reduce uncertainty and create a more level playing field for all companies. This requires investing in government relations and building strong relationships with key stakeholders. The regulatory landscape for CBD is constantly evolving, and proactive engagement with policymakers is essential for long-term success.

Market capitalization of $0.02 billion indicates a micro-cap company with high volatility potential.
Negative profit margin of -547.6% reflects significant operational inefficiencies and challenges in achieving profitability.
Gross margin of -48.1% suggests the company is selling products at a loss before considering operating expenses.
The company operates in the rapidly evolving and highly competitive cannabidiol (CBD) market.
Chill Brands Group PLC changed its name from Zoetic International PLC in August 2021, signaling a strategic shift in branding and market focus.

CHBRF提供哪些产品和服务？

Researches and develops cannabidiol (CBD) consumer products.
Produces a range of CBD-infused products, including tobacco alternatives.
Sells CBD products in the United States, the United Kingdom, and Europe.
Offers tobacco alternative products like smokes and chew pouches.
Provides oral tinctures and soft-gel capsules.
Manufactures massage oils and topical cosmetic products.
Markets its products under the Chill.com and Zoetic brands.

CHBRF如何赚钱？

Develops and manufactures CBD-infused consumer products.
Sells products through online channels and retail partnerships.
Generates revenue from the sale of CBD products in the US, UK, and Europe.

Consumers seeking alternatives to traditional tobacco products.
Individuals interested in CBD-infused wellness products.
Customers in the United States, the United Kingdom, and Europe.

Brand recognition through the Chill.com and Zoetic brands.
Proprietary formulations and manufacturing processes for CBD products.
Established distribution network in the US, UK, and Europe.

什么因素可能推动CHBRF股价上涨？

Upcoming: Potential regulatory changes in the US, UK, and Europe regarding CBD products could create new market opportunities or pose additional challenges.
Ongoing: Expansion of the company's product portfolio with new CBD-infused products targeting specific health and wellness needs.
Ongoing: Strategic partnerships with established retailers and distributors to expand market reach.
Ongoing: Increased consumer awareness of the potential health benefits of CBD products.
Ongoing: Development of a strong online presence and e-commerce platform to drive direct-to-consumer sales.

CHBRF的主要风险是什么？

Ongoing: Evolving regulatory landscape for CBD products in the US, UK, and Europe.
Ongoing: Intense competition in the CBD market from established players and new entrants.
Potential: Fluctuations in consumer demand for CBD products.
Potential: Negative publicity or adverse health effects associated with CBD products.
Ongoing: Limited financial resources and negative profitability.

CHBRF的核心优势是什么？

Established brands (Chill.com and Zoetic).
Presence in multiple geographic markets (US, UK, Europe).
Diverse product portfolio of CBD-infused products.

CHBRF的劣势是什么？

Negative profit margin and gross margin.
Small market capitalization.
Limited financial resources.

CHBRF有哪些机遇？

Expansion into new geographic markets.
Development of new CBD-infused products.
Strategic partnerships with established retailers.

CHBRF面临哪些威胁？

Evolving regulatory landscape for CBD products.
Intense competition in the CBD market.
Fluctuations in consumer demand for CBD products.

CHBRF的竞争对手是谁？

Australis Capital Inc. — Focuses on cannabis investments and operations. — (ATHJF)
BevCanna Enterprises Inc. — Develops and manufactures cannabis-infused beverages and products. — (BFFTF)
Emerald Health Therapeutics Inc. — Cultivates and processes cannabis for medical and recreational markets. — (EMMLF)
General Hemp Corp — Operates in the hemp and CBD industry. — (GENH)
The Gram Co Inc. — Focuses on cannabis cultivation and retail operations. — (GRAMF)

Key Metrics

MoonshotScore: 38/100

Company Profile

CEO: Graham John William Duncan
Headquarters: London, GB
Employees: 7
Founded: 2015

AI Insight

AI analysis pending for CHBRF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Chill Brands Group PLC do?

Chill Brands Group PLC operates in the cannabidiol (CBD) consumer products market, focusing on the research, development, production, and sale of CBD-infused goods. The company offers a range of products, including tobacco alternatives like smokes and chew pouches, as well as oral tinctures, soft-gel capsules, massage oils, and topical cosmetic products. These products are marketed under the Chill.com and Zoetic brands and are sold in the United States, the United Kingdom, and Europe. The company aims to capitalize on the growing demand for CBD products by offering a diverse portfolio of wellness-focused items.

What do analysts say about CHBRF stock?

As of 2026-03-16, there is no readily available analyst consensus on CHBRF stock due to its OTC listing and small market capitalization. Key valuation metrics such as the negative P/E ratio of -1.35 and negative profit margin of -547.6% suggest financial challenges. Growth considerations depend on the company's ability to navigate the evolving regulatory landscape, expand its product portfolio, and achieve profitability. Investors should conduct thorough due diligence and consider the risks associated with investing in OTC-listed stocks.

What are the main risks for CHBRF?

Chill Brands Group PLC faces several key risks, including the evolving regulatory landscape for CBD products in the US, UK, and Europe, which could impact its ability to market and sell its products. Intense competition in the CBD market from established players and new entrants poses a threat to its market share. Fluctuations in consumer demand for CBD products and potential negative publicity or adverse health effects associated with CBD could also negatively impact the company's performance. Additionally, the company's limited financial resources and negative profitability present significant challenges to its long-term sustainability.